Form 483

Stembanc Inc Form 483, 2014-02-12

FDA issued a Form 483 to Stembanc Inc on 2014-02-12 with 6 public-safe observations.

483· Form 483 issuedBiologics6 observations

Stembanc Inc · Chardon, United States · Issued February 12, 2014

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Feb 2014
21 CFR 1271.80(a)

Birth mother sample not tested

Cited by Nancy L Neiger

12 Feb 2014
21 CFR 1271.160(b)(6)

Deviations--evaluation, cause, corrective action

Cited by Nancy L Neiger

12 Feb 2014
21 CFR 1271.160(c)

Quality audits performed periodically

Cited by Nancy L Neiger

12 Feb 2014
21 CFR 1271.220(a)

Causing contamination, increasing risks

Cited by Nancy L Neiger

12 Feb 2014
21 CFR 1271.230(a)

Validation & approval--established procedures

Cited by Nancy L Neiger

Inspected site

SIStembanc IncChardon, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.160(b)(6)Cited across public-safe Form 483 observations1x
21 CFR 1271.160(c)Cited across public-safe Form 483 observations1x
21 CFR 1271.220(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.230(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.265(e)Cited across public-safe Form 483 observations1x
21 CFR 1271.80(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere